Justin Yan Chen
Geschäftsführer bei Tongjitang Chinese Medicines Co.
Profil
Justin Yan Chen is currently the Chief Operating Officer & Executive Director at Tongjitang Chinese Medicines Co. He previously worked as the Head-Project Investment at Citychamp Watch & Jewellery Group Ltd.
Mr. Chen holds an MBA from the University of Lancaster and an undergraduate degree from the University of International Business & Economics.
Aktive Positionen von Justin Yan Chen
| Unternehmen | Position | Beginn |
|---|---|---|
Tongjitang Chinese Medicines Co.
 Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | Geschäftsführer | 07.12.2009 |
Ehemalige bekannte Positionen von Justin Yan Chen
| Unternehmen | Position | Ende |
|---|---|---|
| CITYCHAMP WATCH & JEWELLERY GROUP LIMITED | Corporate Officer/Principal | - |
Ausbildung von Justin Yan Chen
| University of Lancaster | Masters Business Admin |
| University of International Business & Economics | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CITYCHAMP WATCH & JEWELLERY GROUP LIMITED | Producer Manufacturing |
| Private Unternehmen | 1 |
|---|---|
Tongjitang Chinese Medicines Co.
Tongjitang Chinese Medicines Co. Pharmaceuticals: MajorHealth Technology Tongjitang Chinese Medicines Co. is a pharmaceutical company engaged in the development, manufacture, marketing, and sale of modernized Chinese medicine. It offers products that are used for the treatment of osteoporosis, insomnia and improvement of sleep quality, itchiness, vertigo, side-effects of radiotherapy and chemotherapy, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and osteoarthritis or cervical spondylosis. The company was founded in December 1995 and is headquartered in Shenzhen, China. | Health Technology |
